Therapeutic vaccines help to treat diseases by strengthening the immunity. Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years.

Europe Therapeutic Vaccines Market is estimated at $704.85 Million in 2018 and is poised to reach $2767.34 Million by 2023 with a CAGR of 31.46%.

The therapeutic vaccine Market differs from any other commodity market because compared its relatively small size, it appears to be doing well. It is because the vaccine market is rather concentrated on both supply and demand sides. Though, it is highly regulated in the Europe region and mostly dependent on public purchasers and donor policies, it seems to be thriving due to recent onset of many epidemics and well availability of resources in this particular region. Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.

Traditionally, Multinational companies paved way for much of the innovation, R&D in this field. They have used significant revenues and deeper expertise to fund their flagship projects. To note, some of the key players influencing the Europe preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

Research Methodology

2.1 Introduction

2.2 Analysis Design

2.3 Research Phases

2.3.1 Secondary Research

2.3.2 Primary Research

2.3.3 Econometric Modelling

2.3.4 Expert Validation

2.4 Study Timeline

Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 New Developments

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

Market Segmentation

5.1 By Disease Type

5.1.1 Autoimmune Disease Vaccines

5.1.2 Cancer Vaccines

5.1.2.1 Multikine

5.1.2.2 PR1 Peptide

5.1.2.3 TroVax

5.1.2.4 CYT004-MelQbG10

5.1.3 Neurological Disease Vaccines

5.1.3.1 ACC- 001

5.1.3.2 CAD 106

5.1.3.3 Parkinson's Disease Vaccine

5.1.3.4 Alzheimer's Disease

5.1.4 Infectious Disease Vaccines

5.1.4.1 Hepatitis C

5.1.4.2 HIV/AIDS

5.1.4.3 Other Infectious Disease

Geographical Analysis

6.1 Introduction

6.2 U.K

6.3 Spain

6.4 Germany

6.5 Italy

6.6 France

Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

Market Leaders' Analysis

8.1 GlaxoSMithKline plc.

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Strategic Evaluation and Operations

8.1.4 Financial analysis

8.1.5 Legal issues

8.1.6 Recent Developments

8.1.7 SWOT analysis

8.1.8 Analyst View

8.2 Merck and Company

8.3 Bavarian Nordic

8.4 CSL Limited

8.5 Emergent Biosolutions Inc.

8.6 Novartis AG

8.7 Johnson and Johnson

8.8 MedImmune LLC

8.9 Pfizer Inc.

8.10 Sanofi Pasteur

Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

Expert Opinions

10.1 Market Outlook

10.2 Investment Opportunities

Appendix

List of Tables

List of Figures

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market